Real-world evidence (RWE) data estimate 19.8% relative vaccine effectiveness (rVE) of cell-based quadrivalent influenza vaccines (QIVc) versus standard ...
CSL Seqirus real-world study finds cell-based flu vaccines offer stronger protection than egg-based options in 2023/24 season.
October 22, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its ...
Researchers in China have raised increasing concerns about the potential spread of a troubling flu variant capable of transmitting from cattle to humans. A recent study has shown that a virus ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports ...
Group sales In the first nine months of 2025, Roche achieved sales growth of 7% (2% in CHF) to CHF 45.9 billion due to strong demand for our pharmaceutical and diagnostic products.
The sixth European Society of Clinical Microbiology and Infectious Diseases Conference on Vaccines took place in Lisbon, ...
Patients with advanced lung or skin cancers who received a COVID-19 mRNA vaccine within one hundred days of starting ...
I do not recommend stopping aspirin without discussing with your doctor. Dr. Roach: Would it be risky to take a low dose (20 mg) of over-the-counter lithium orotate to treat cognitive decline? The ...
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease ...
The University of Wyoming will host its 11th annual UW Giving Day from noon Thursday, Oct. 23, to noon Friday, Oct. 24, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback